Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel

Serotonin-gated ion channels (5-HT3) are members of the ligand-gated channel family, which includes channels that are opened directly by the neurotransmitter acetylcholine, GABA, glycine, or glutamate. Although there is general agreement that the second transmembrane domain (M2) lines the pore, the position of the gate in the M2 is less certain. Here, we used substituted cysteine accessibility method (SCAM) to provide new evidence for a centrally located gate that moves during channel activation. In the closed state, three cysteine substitutions, located on the extracellular side of M2, were modified by methanethiosulfonate (MTS) reagents. In contrast, 13 cysteine substitutions were modified in the open state with MTS reagents. The pattern of inhibition (every three to four substitutions) was consistent with an α helical structure for the middle and cytoplasmic segments of the M2 transmembrane domain. Unexpectedly, open-state modification of two amino acids in the center of M2 with three different MTS reagents prevented channels from fully closing in the absence of neurotransmitter. Our results are consistent with a model in which the central region of the M2 transmembrane domain is inaccessible in the closed state and moves during channel activation.

[1]  D. Salgado-Commissariat,et al.  Induction and maintenance of ganglionic long‐term potentiation require activation of 5‐hydroxytryptamine (5‐HT3) receptors. , 1996, The Journal of physiology.

[2]  Francisco Bezanilla,et al.  Histidine Scanning Mutagenesis of Basic Residues of the S4 Segment of the Shaker K+ Channel , 2001, The Journal of general physiology.

[3]  J. Changeux,et al.  Paradoxical allosteric effects of competitive inhibitors on neuronal α7 nicotinic receptor mutants , 1997, Neuroreport.

[4]  G N Filatov,et al.  The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating. , 1995, Molecular pharmacology.

[5]  Lixin Tang,et al.  Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors , 1995, Nature.

[6]  J. Ballesteros,et al.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.

[7]  G. Yellen,et al.  On the Use of Thiol-modifying Agents to Determine Channel Topology , 1996, Neuropharmacology.

[8]  Z. Pan,et al.  Agonist-induced closure of constitutively open gamma-aminobutyric acid channels with mutated M2 domains. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Otto E. Albrecht I. The Manuscript , 1935 .

[10]  G. Wilcox,et al.  Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  G. Yellen,et al.  Gated Access to the Pore of a Voltage-Dependent K+ Channel , 1997, Neuron.

[12]  E. Perez 5‐HT3 antiemetic therapy for patients with breast cancer , 1999, Breast Cancer Research and Treatment.

[13]  N. Unwin Acetylcholine receptor channel imaged in the open state , 1995, Nature.

[14]  Y. Fujiyoshi,et al.  Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall. , 1999, Journal of molecular biology.

[15]  R. Myers,et al.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.

[16]  J. Changeux,et al.  Nicotinic receptors at the amino acid level. , 2000, Annual review of pharmacology and toxicology.

[17]  Nicolas Le Novère,et al.  The Ligand Gated Ion Channel Database , 1999, Nucleic Acids Res..

[18]  R. North,et al.  Single amino acid substitution affects desensitization of the 5-hydroxytryptamine type 3 receptor expressed in Xenopus oocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Akabas,et al.  Structural and Electrostatic Properties of the 5-HT3Receptor Pore Revealed by Substituted Cysteine Accessibility Mutagenesis* , 2001, The Journal of Biological Chemistry.

[20]  C. Glass,et al.  The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit* , 1999, The Journal of Biological Chemistry.

[21]  L. Tecott,et al.  Nervous system distribution of the serotonin 5-HT3 receptor mRNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Howorka,et al.  Location of a Constriction in the Lumen of a Transmembrane Pore by Targeted Covalent Attachment of Polymer Molecules , 2001, The Journal of general physiology.

[23]  A. Auerbach,et al.  A distinct contribution of the delta subunit to acetylcholine receptor channel activation revealed by mutations of the M2 segment. , 1998, Biophysical journal.

[24]  K. Ohno,et al.  Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating , 1999, Nature Neuroscience.

[25]  S. Kaneko,et al.  Inhibitory influence via 5-HT3 receptors on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal slices , 1994, Neuroscience Research.

[26]  B. Birnir,et al.  Mutating the Highly Conserved Second Membrane-Spanning Region 9 9 Leucine Residue in the a 1 or b 1 Subunit Produces Subunit-Specific Changes in the Function of Human a 1 b 1 g-Aminobutyric AcidA Receptors , 2000 .

[27]  D. S. Weiss,et al.  Substitutions of the highly conserved M2 leucine create spontaneously opening rho1 gamma-aminobutyric acid receptors. , 1998 .

[28]  A. Karlin,et al.  Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the α subunit , 1994, Neuron.

[29]  W. N. Zagotta,et al.  Conformational Changes in S6 Coupled to the Opening of Cyclic Nucleotide-Gated Channels , 2001, Neuron.

[30]  A. Karlin,et al.  Contribution of the beta subunit M2 segment to the ion-conducting pathway of the acetylcholine receptor. , 1998, Biochemistry.

[31]  A Karlin,et al.  Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Miledi,et al.  Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Gesell,et al.  Structures of the M2 channel-lining segments from nicotinic acetylcholine and NMDA receptors by NMR spectroscopy , 1999, Nature Structural Biology.

[34]  A. Macdermott,et al.  Presynaptic ionotropic receptors and control of transmitter release , 2004, Nature Reviews Neuroscience.

[35]  A. Karlin,et al.  The Location of the Gate in the Acetylcholine Receptor Channel , 1998, Neuron.

[36]  K. A. Jones,et al.  Functional properties of a cloned 5‐hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. , 1994, The Journal of physiology.

[37]  R. Miledi,et al.  Strychnine activates neuronal alpha7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Birnir,et al.  Mutating the highly conserved second membrane-spanning region 9' leucine residue in the alpha(1) or beta(1) subunit produces subunit-specific changes in the function of human alpha(1)beta(1) gamma-aminobutyric Acid(A) receptors. , 2000, Molecular pharmacology.

[39]  S. Khasabov,et al.  Modulation of afferent‐evoked neurotransmission by 5‐HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5‐HT3 induced anti‐nociception , 1999, British journal of pharmacology.

[40]  H. Lester,et al.  Backbone Mutations in Transmembrane Domains of a Ligand-Gated Ion Channel Implications for the Mechanism of Gating , 1999, Cell.

[41]  J. Gouaux,et al.  Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane Pore , 1996, Science.

[42]  John A. Peters,et al.  The 5-HT3B subunit is a major determinant of serotonin-receptor function , 1999, Nature.

[43]  J. Changeux,et al.  Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities , 1993, Nature.

[44]  A. Karlin,et al.  State-dependent Accessibility and Electrostatic Potential in the Channel of the Acetylcholine Receptor , 1998, The Journal of general physiology.

[45]  D. Cox,et al.  Functional Effects of the Mouse weaver Mutation on G Protein–Gated Inwardly Rectifying K+ Channels , 1996, Neuron.

[46]  H. Lester,et al.  Probing the role of a conserved M1 proline residue in 5-hydroxytryptamine(3) receptor gating. , 2000, Molecular pharmacology.